Clearmind Medicine Inc.(CMND US)
$5.97-0.152.52%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions CAD (ex. Per Share) | FY201710/31/2017 | FY201810/31/2018 | FY201910/31/2019 | FY202010/31/2020 | FY202110/31/2021 | FY202210/31/2022 | FY202310/31/2023 | FY202410/31/2024 | FY202510/31/2025 | Last 12M04/30/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -12.1 | -10.3 | -5.4 | -12.2 | ||||||||
| Depreciation & Amortization | 0.1 | 0.1 | 0.1 | 0.1 | ||||||||
| Stock Based Compensation | - | 2.0 | 1.1 | 2.4 | ||||||||
| Change in Working Capital | -1.4 | -0.3 | -0.1 | 0.0 | ||||||||
| Other Non-Cash Items | 4.5 | -1.2 | -2.5 | -0.4 | ||||||||
| Net Cash from Operating Activities | -8.9 | -9.5 | -6.7 | -10.1 | ||||||||
| -Investments in Property, Plant & Equipment | - | - | - | - | ||||||||
| -Acquisitions Net | - | - | - | - | ||||||||
| -Purchases of Investments | - | -0.7 | -1.0 | -1.9 | ||||||||
| Sales/Maturities of Investments | - | 0.2 | 0.3 | 0.2 | ||||||||
| Other Investing Activities | -0.0 | 0.1 | -0.0 | - | ||||||||
| Net Cash from Investing Activities | -0.0 | -0.5 | -0.8 | -1.7 | ||||||||
| Net Debt Issuance | -0.1 | -0.1 | 3.1 | 10.8 | ||||||||
| Net Stock Issuance | 15.6 | 4.3 | 0.6 | 10.6 | ||||||||
| -Net Dividends Paid | - | - | - | - | ||||||||
| Other Financing Activities | 0.8 | 8.0 | - | -0.0 | ||||||||
| Net Cash from Financing Activities | 16.4 | 12.2 | 3.7 | 21.4 | ||||||||
| Effect of Forex Changes | -0.1 | -0.0 | 0.0 | -0.1 | ||||||||
| Net Change in Cash | 7.4 | 2.2 | -3.7 | 9.5 | ||||||||
| Cash at End of Period | 7.6 | 12.9 | 5.5 | 43.6 | ||||||||
| Operating Cash Flow | -8.9 | -9.5 | -6.7 | -10.1 | ||||||||
| -Capital Expenditure | - | - | - | - | ||||||||
| Free Cash Flow | -8.9 | -9.5 | -6.7 | -10.1 | ||||||||